Detalhe da pesquisa
1.
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.
Cancer Immunol Immunother
; 73(6): 106, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38634928
2.
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study).
Future Oncol
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38682738
3.
Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study.
Cancer Immunol Immunother
; 72(9): 2961-2970, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37248424
4.
Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study.
Cancer Immunol Immunother
; 72(11): 3665-3682, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37676282
5.
Steroid Hormones as Modulators of Emotional Regulation in Male Urogenital Cancers.
Int J Behav Med
; 30(6): 836-848, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36459332
6.
Surgical treatment of recurrent retroperitoneal sarcoma in its different patterns: A 15-years' two-centers experience.
Surgeon
; 21(5): e249-e257, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36707317
7.
The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs.
J Transl Med
; 20(1): 371, 2022 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35974365
8.
The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study.
J Transl Med
; 20(1): 435, 2022 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36180954
9.
Avelumab treatment in Italian patients with metastatic Merkel cell carcinoma: experience from an expanded access program.
J Transl Med
; 19(1): 70, 2021 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33588870
10.
An Italian, multicenter, real-world, retrospective study of first-line pazopanib in unselected metastatic renal-cell carcinoma patients: the 'Pamerit' study.
Jpn J Clin Oncol
; 51(3): 484-491, 2021 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33212499
11.
[18F]Fluorocholine PET/CT-guided stereotactic body radiotherapy in patients with recurrent oligometastatic prostate cancer.
Eur J Nucl Med Mol Imaging
; 47(1): 185-191, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31620808
12.
Fracture risk and survival outcomes in metastatic castration-resistant prostate cancer patients sequentially treated with abiraterone acetate and RADIUM-223.
Eur J Nucl Med Mol Imaging
; 47(11): 2633-2638, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32249345
13.
Dedifferentiated liposarcoma: when eribulin can make the difference.
Future Oncol
; 16(1s): 21-24, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31872768
14.
Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results.
J Transl Med
; 17(1): 296, 2019 08 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31464635
15.
Androgen receptor (AR) splice variant 7 and full-length AR expression is associated with clinical outcome: a translational study in patients with castrate-resistant prostate cancer.
BJU Int
; 124(4): 693-700, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31055861
16.
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme.
BJU Int
; 123(1): 98-105, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29956884
17.
The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma.
Anticancer Drugs
; 29(7): 705-709, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29846246
18.
Negative prognostic factors and resulting clinical outcome in patients with metastatic renal cell carcinoma included in the Italian nivolumab-expanded access program.
Future Oncol
; 14(14): 1347-1354, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29774766
19.
Outcome of Patients with Renal Cell Carcinoma and Multiple Glandular Metastases Treated with Targeted Agents.
Oncology
; 92(5): 269-275, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28208153
20.
Sirolimus in Advanced Epithelioid Hemangioendothelioma: A Retrospective Case-Series Analysis from the Italian Rare Cancer Network Database.
Ann Surg Oncol
; 23(9): 2735-44, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27334221